Danicamtiv is an investigational selective agonist of cardiac myosin, intended to help myocyte contraction by enhancing ...

A Savannah teenager is making national medical history after surviving a surgery so rare that only one other person in the country has ever recovered well enough to leave the hospital. 18-year-old ...

Background Hospitalisation with acute heart failure (AHF) carries a high risk of death, and those surviving to discharge ...

CorWave presented positive interim results from its first-in-human study of the CorWave Left Ventricular Assisting System ...